Saudi Journal of Gastroenterology
Home About us Instructions Submission Subscribe Advertise Contact Login    Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Users Online: 1157 

    Article Cited by others

ORIGINAL ARTICLE

Efficacy and safety of drotaverine hydrochloride in irritable bowel syndrome: A randomized double-blind placebo-controlled study

Rai Ramesh R, Dwivedi Manisha, Kumar Nirmal

Year : 2014| Volume: 20| Issue : 6 | Page no: 378-382

   This article has been cited by
 
1 The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis
Michelle Bosman, Sigrid Elsenbruch, Maura Corsetti, Jan Tack, Magnus Simrén, Bjorn Winkens, Thimo Boumans, Ad Masclee, Daniel Keszthelyi
The Lancet Gastroenterology & Hepatology. 2021; 6(6): 459
[Pubmed]  [Google Scholar] [DOI]
2 Chinese herbal medicine versus antispasmodics in the treatment of irritable bowel syndrome: A network meta-analysis
Min Chen, Di Qin, Shi-Le Huang, Tai-Chun Tang, Hui Zheng
Neurogastroenterology & Motility. 2021; 33(8)
[Pubmed]  [Google Scholar] [DOI]
3 Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea
Esther Colomier, Joost Algera, Chloé Melchior
Frontiers in Pharmacology. 2021; 11
[Pubmed]  [Google Scholar] [DOI]
4 Antispasmodics in irritable bowel syndrome – a hoary old chestnut?
Anna Pietrzak
Saudi Journal of Gastroenterology. 2021; 27(3): 113
[Pubmed]  [Google Scholar] [DOI]
5 An update on efficacy and safety considerations for the latest drugs used to treat irritable bowel syndrome
Taraneh Mousavi, Shekoufeh Nikfar, Mohammad Abdollahi
Expert Opinion on Drug Metabolism & Toxicology. 2020; 16(7): 583
[Pubmed]  [Google Scholar] [DOI]
6 Pharmacotherapy of irritable bowel syndrome
Jan Jurica, Radek Kroupa
Praktické lékárenství. 2017; 13(2): 52
[Pubmed]  [Google Scholar] [DOI]

 

Read this article